Treatment of Medication Overuse Headache
The cornerstone of treating medication overuse headache is withdrawal of the overused acute medication combined with initiation of preventive therapy, supported by patient education about the relationship between frequent medication use and headache chronification. 1
Understanding Medication Overuse Headache
Medication overuse headache occurs when headaches develop on ≥15 days per month for at least 3 months in patients with a pre-existing headache disorder due to overuse of acute medication. Critical thresholds vary by medication class: ≥15 days per month for NSAIDs versus ≥10 days per month for triptans 1. This distinction is essential for diagnosis and counseling.
Treatment Algorithm
Step 1: Patient Education (First-Line)
Begin with structured education about the MOH concept, explaining that frequent use of acute medications paradoxically worsens headache frequency. This educational intervention alone is effective in many patients and should address:
- The relationship between medication frequency and headache chronification
- Risk factors including headache frequency ≥7 days/month, anxiety/depression, physical inactivity, and smoking 2
- Treatment options and realistic expectations
- The goal of limiting acute medication use 1, 3, 4
Education should be delivered by a multidisciplinary team including neurologists and behavioral psychologists 4.
Step 2: Initiate Preventive Therapy
If education alone fails to reduce medication overuse, immediately start preventive medication while addressing the overuse 3, 4. This represents a paradigm shift from older detoxification-first approaches.
For chronic migraine with medication overuse, use:
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) - these are highly effective and can be initiated before or alongside withdrawal 2, 5
- OnabotulinumtoxinA - proven efficacy in chronic migraine with medication overuse 3
- Topiramate - effective for both episodic and chronic migraine prevention 2, 3
For tension-type headache with medication overuse:
- Amitriptyline is the preventive agent of choice 3
Step 3: Medication Withdrawal
If Steps 1 and 2 are insufficient, proceed with formal withdrawal of the overused medication.
Withdrawal strategy depends on the medication class:
Abrupt withdrawal (preferred for most):
Gradual tapering (mandatory for):
- Opioids - requires inpatient withdrawal 3, 4
- Barbiturates (butalbital-containing compounds)
- Benzodiazepines 4
Setting for withdrawal:
- Outpatient basis for most patients with simple analgesic or triptan overuse
- Day hospital for moderate severity
- Inpatient setting mandatory for opioid overuse and patients with significant comorbidities 3, 4, 6
Step 4: Bridging Therapy for Withdrawal Symptoms
During the withdrawal period, use bridging medications to manage withdrawal headaches and symptoms:
- Tricyclic antidepressants (e.g., amitriptyline)
- Neuroleptics/antiemetics (e.g., prochlorperazine, metoclopramide)
- Corticosteroids for short-term use during acute withdrawal 3, 7
These medications help patients tolerate the withdrawal process, which typically worsens pre-existing headaches temporarily.
Critical Pitfalls to Avoid
Do not use opioids or butalbital for acute migraine treatment - these medications have the highest risk of MOH development and the worst relapse rates 1, 8. The 2025 American College of Physicians guideline explicitly states to avoid these agents.
Do not delay preventive therapy until after withdrawal is complete - modern evidence supports concurrent or even preventive-first approaches, particularly with CGRP-targeted therapies 5, 9.
Do not attempt outpatient withdrawal for opioid overuse - these patients require inpatient management due to higher relapse rates and withdrawal complications 3, 4.
Behavioral and Lifestyle Interventions
Supplement pharmacologic treatment with:
- Cognitive behavioral therapy to address catastrophizing and cephalalgiophobia
- Mindfulness-based approaches
- Regular aerobic exercise (moderate to intense)
- Consistent sleep schedules
- Stress management techniques
- Adequate hydration and regular meals 1, 5
Expected Outcomes and Follow-up
Success rates are 50-70% at 6-12 months with the stepped treatment approach 3, 6. However, opioid overuse has significantly higher relapse rates 6.
Close monitoring and ongoing patient education reduce relapse risk 3, 6. Assess treatment efficacy after 2-3 months for oral preventives, 3-6 months for CGRP monoclonal antibodies, and 6-9 months for onabotulinumtoxinA 8.
Consider pausing preventive therapy after 6-12 months of successful treatment to determine if ongoing prevention is necessary 8.